Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron
Yuchen Wei, Katherine Min Jia, Shi Zhao, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e2254777-e2254777
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study
Michela Antonelli, Rose Penfold, Liane S. Canas, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 506-515
Open Access | Times Cited: 22
COVID-19: From emerging variants to vaccination
Thilini H. Senevirathne, Demi Wekking, Joseph W. R. Swain, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 76, pp. 127-141
Closed Access | Times Cited: 16
Understanding low COVID-19 booster uptake among US adults
Elizabeth T. Jacobs, Felina M. Cordova-Marks, Leslie V. Farland, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6221-6226
Closed Access | Times Cited: 15
Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications, Efficacy, and Adverse Effects of Inactivated Whole-Virus COVID-19 Vaccines Sinopharm, CoronaVac, and Covaxin: An Observational Study
Sultan Ayoub Meo, Riham A. ElToukhy, Anusha Sultan Meo, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 826-826
Open Access | Times Cited: 14
Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020–2023): a multicentre prospective cohort study
Anis Karuniawati, Ayodhia Pitaloka Pasaribu, L Gilbert, et al.
The Lancet Regional Health - Southeast Asia (2024) Vol. 22, pp. 100348-100348
Open Access | Times Cited: 5
Severe COVID-19 Pneumonia, Opportunistic Candida krusei Infection, and Acute Respiratory Distress Syndrome with Pulmonary Arterial Hypertension Treated with Bosentan: A Case Report
Killen H. Briones‐Claudett, Killen H. Briones-Zamora, Jaime Galo Benites Solis, et al.
American Journal of Case Reports (2025) Vol. 26
Closed Access
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation
Yuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
Emerging Microbes & Infections (2025)
Open Access
Post-pandemic excess mortality of COVID-19 in Hong Kong: a retrospective study
Kehang Li, Yuchen Wei, C.T. Hung, et al.
The Lancet Regional Health - Western Pacific (2025) Vol. 58, pp. 101554-101554
Closed Access
Comparative duration of neutralizing responses and protections of COVID-19 vaccination and correlates of protection
Chang Liu, Tim K. Tsang, Sheena G. Sullivan, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Effectiveness of COVID-19 Vaccines Over Time Against Clinical and Radiologic Outcomes Related to Severe SARS-CoV-2 Infection
Jong Eun Lee, Kwang Nam Jin, Hyunsook Hong, et al.
Radiology (2024) Vol. 310, Iss. 1
Closed Access | Times Cited: 3
Association between Gut Microbiota Composition and Long-Term Vaccine Immunogenicity following Three Doses of CoronaVac
Lina Zhang, Jing Tong Tan, Ho Yu Ng, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 365-365
Open Access | Times Cited: 3
Effectiveness of inactivated COVID-19 vaccines in preventing COVID-19-related hospitalization during the Omicron BF.7-predominant epidemic wave in Beijing, China: a cohort study
Dan Zhao, Ying Sun, Juan Li, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Association between vaccination status and severe health consequences among community-dwelling COVID-19 patients during Omicron BA.1/BA.2 and BA.5-predominant periods in Japan
Kimiko Tomioka, Kenji Uno, Masahiro Yamada
Environmental Health and Preventive Medicine (2023) Vol. 28, pp. 35-35
Open Access | Times Cited: 7
Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong population
Rita W. Y. Ng, Ryan K.H. Sze, Ka Chun Chong, et al.
Journal of Infection (2023) Vol. 87, Iss. 2, pp. 136-143
Open Access | Times Cited: 6
Longitudinal analysis of memory Tfh cells and antibody response following CoronaVac vaccination
Pengcheng Zhou, Cheng Cao, Tuo Ji, et al.
JCI Insight (2023) Vol. 8, Iss. 15
Open Access | Times Cited: 6
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak
Xinrui Wang, Yi Zhang, Chong Huang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
COVID-19 vaccination modified the effect of nirmatrelvir–ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study
Huwen Wang, Yuchen Wei, Guozhang Lin, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
COVID-19 inactivated and non-replicating viral vector vaccines induce regulatory training phenotype in human monocytes under epigenetic control
Mateus da Silva Matias Antunes, Fabrícia Heloisa Cavicchioli Sugiyama, Humberto Doriguêtto Gravina, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 5
Antibodies to S2 domain of SARS-CoV-2 spike protein in Moderna mRNA vaccinated subjects sustain antibody-dependent NK cell-mediated cell cytotoxicity against Omicron BA.1
Corey A. Balinsky, Le Jiang, Vihasi Jani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Temporary impact on medical system and effectiveness of mitigation strategies after COVID-19 policy adjustment in China: a modeling study
Chitin Hon, Jingyi Liang, Ruihan Chen, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 4
Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients
Michael Kwan Leung Yu, H.S. Chan, Daniel Leung, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
COVID-19 vaccination and infection status: a cross-sectional survey of patients with rheumatic diseases in China
Chen Chen, S. Huang, Linyu Geng, et al.
Rheumatology International (2023) Vol. 44, Iss. 4, pp. 703-713
Closed Access | Times Cited: 3
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
Clinical and virological features of asymptomatic and mild symptomatic patients with SARS‐CoV‐2 Omicron infection at Shanghai Fangcang shelter hospital
Lin Zhang, Xiaoyu Kang, Liangliang Wang, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 2
Effectiveness of first and second boost COVID-19 vaccination in healthy adults during BA.5.2/BF.7 surge in China
Yongchang Zhang, Zehong Huang, Shucheng Zhuang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top